Current therapies in rheumatoid arthritis: a Latin American perspective.

Current therapies in rheumatoid arthritis: a Latin American perspective.

Item
http://www.wikidata.org/entity/Q38075662
From the model of integral attention to the creation of centers of excellence in rheumatoid arthritisRheumatoid arthritis in Latin America: challenges and solutions to improve its diagnosis and treatment training for medical professionalsEconomic impact of expanded use of biologic therapy for the treatment of rheumatoid arthritis and Crohn's disease in Argentina, Brazil, Colombia, and Mexico.STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population.Rheumatoid arthritis in Latin America. Important challenges to be solved.Biosimilars Have Arrived: Rituximab.Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin AmericaTofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses
P2860

Current therapies in rheumatoid arthritis: a Latin American perspective.

Item
http://www.wikidata.org/entity/Q38075662
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current therapies in rheumatoid arthritis: a Latin American perspective.
@en
type
label
Current therapies in rheumatoid arthritis: a Latin American perspective.
@en
prefLabel
Current therapies in rheumatoid arthritis: a Latin American perspective.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Current therapies in rheumatoid arthritis: a Latin American perspective
@en
P2093
P304
P31
P356
10.1016/J.REUMA.2012.09.001
P433
P478
P50
P577
P5875
P698